1236254-73-1 Usage
Drug Class
Diuretic
Primary Use
Treatment of high blood pressure and fluid retention
Mechanism of Action
Increases urine production to decrease fluid buildup in the body
Administration
Orally as a tablet or liquid
Dosage
To be determined by healthcare professional
Side Effects
Dizziness, lightheadedness, dehydration
Severe Side Effects
Require immediate medical attention
Interactions
Potential interactions with other medications
Importance
Valuable in managing high blood pressure and fluid retention caused by various conditions
Check Digit Verification of cas no
The CAS Registry Mumber 1236254-73-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,3,6,2,5 and 4 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1236254-73:
(9*1)+(8*2)+(7*3)+(6*6)+(5*2)+(4*5)+(3*4)+(2*7)+(1*3)=141
141 % 10 = 1
So 1236254-73-1 is a valid CAS Registry Number.
1236254-73-1Relevant articles and documents
Development of new catalytic enantioselective formation of methylenelactam-based N,O-spirocyclic compounds via ring opening-asymmetric reclosure of hydroxylactams
Sengoku, Tetsuya,Miyoshi, Ayako,Tsuda, Tamaki,Inuzuka, Toshiyasu,Sakamoto, Masami,Takahashi, Masaki,Yoda, Hidemi
, (2020/05/18)
Catalytic enantioselective formation of methylenelactam-based N,O-spirocyclic compounds is developed. Hydroxylactams prepared from N-carbonyl phthalimides and β-amido functionalized allylboronates underwent ring opening-asymmetric reclosure in the presence of catalytic amounts of MgBr2 and a chiral aminophenol to afford the corresponding N,O-spirocyclic compounds in excellent yields and high enantioselectivities.
